Global Companion Diagnostic Development Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Companion Diagnostic Development Services market size was valued at US$ 1811 million in 2025 and is forecast to a readjusted size of US$ 3769 million by 2032 with a CAGR of 10.9% during review period.
Companion diagnostic development services comprise integrated technical, clinical, quality, and regulatory activities provided to pharmaceutical, biotechnology, and diagnostic companies to co-develop an in vitro diagnostic or imaging tool that is essential for the safe and effective use of a corresponding therapy. The service scope covers biomarker strategy, assay selection, reagent and algorithm development, analytical validation, clinical performance studies, clinical trial sample testing, quality-system documentation, global regulatory submissions, technology transfer, commercial deployment, and post-approval change management. Major platforms include next-generation sequencing, PCR and digital PCR, immunohistochemistry and in situ hybridization, flow cytometry, immunoassays, and digital pathology. Programs are generally advanced in parallel with therapeutic development and require coordinated decisions on clinical protocols, specimen strategy, cutoffs, intended use, and regional regulatory pathways. This study focuses on contracted development and validation services supplied to external clients by third-party laboratories, contract research organizations, and diagnostic technology companies, with an estimated blended gross margin of approximately 50%.
Global Companion Diagnostic Development Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Companion Diagnostic Development Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Companion Diagnostic Development Services market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Companion Diagnostic Development Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Chapter 2, to profile the top players of Companion Diagnostic Development Services, with revenue, gross margin, and global market share of Companion Diagnostic Development Services from 2021 to 2026.
Chapter 3, the Companion Diagnostic Development Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Companion Diagnostic Development Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Diagnostic Development Services.
Chapter 13, to describe Companion Diagnostic Development Services research findings and conclusion.
Companion diagnostic development services comprise integrated technical, clinical, quality, and regulatory activities provided to pharmaceutical, biotechnology, and diagnostic companies to co-develop an in vitro diagnostic or imaging tool that is essential for the safe and effective use of a corresponding therapy. The service scope covers biomarker strategy, assay selection, reagent and algorithm development, analytical validation, clinical performance studies, clinical trial sample testing, quality-system documentation, global regulatory submissions, technology transfer, commercial deployment, and post-approval change management. Major platforms include next-generation sequencing, PCR and digital PCR, immunohistochemistry and in situ hybridization, flow cytometry, immunoassays, and digital pathology. Programs are generally advanced in parallel with therapeutic development and require coordinated decisions on clinical protocols, specimen strategy, cutoffs, intended use, and regional regulatory pathways. This study focuses on contracted development and validation services supplied to external clients by third-party laboratories, contract research organizations, and diagnostic technology companies, with an estimated blended gross margin of approximately 50%.
Market Trends
Companion diagnostic programs are shifting from single-marker, single-region projects toward multiplex, platform-based, and globally coordinated development. Drug sponsors increasingly engage diagnostic partners during program planning and early clinical development to reduce the risk of late assay replacement, repeat validation, or additional bridging studies. Comprehensive genomic profiling, liquid biopsy, digital pathology, and AI-enabled quantitative scoring are expanding the range of actionable biomarkers, while competition is moving beyond individual assay capabilities toward cross-platform integration, quality systems, global laboratory harmonization, and commercial deployment.Drivers
Expansion of precision therapeutics, antibody-drug conjugates, immunotherapies, and rare-disease treatments is making patient selection, response prediction, and safety stratification integral to clinical development. Regulatory expectations for coordinated drug and diagnostic development, together with sponsor demand for faster enrollment, shorter timelines, and lower late-stage submission risk, are increasing the use of specialized external partners.Restraints
Growth is constrained by limited access to high-quality clinical specimens, low biomarker prevalence, cross-border sample restrictions, and the cost of platform changes. Because diagnostic timelines must remain synchronized with the therapeutic program, changes in indication, protocol, specimen type, or cutoff can trigger additional validation, bridging, and submission work, increasing cost and delivery uncertainty.Opportunities
New demand is emerging in autoimmune, neurodegenerative, infectious, and cell and gene therapy programs beyond oncology. Local laboratory networks for multiregional trials, distributed kit deployment, single-site regulatory pathways followed by broader geographic expansion, and panel-based diagnostics that can add therapeutic claims over time all provide attractive program-extension opportunities.Challenges
Long-term risks include uncertain clinical utility of novel biomarkers, loss of diagnostic investment when a therapeutic program is discontinued, inconsistent regional requirements, and commercial testing volumes below development expectations. Digital and algorithmic diagnostics must additionally address training-data representativeness, algorithm locking, software change control, laboratory information system integration, and reproducibility across sites.Value Chain Analysis
Upstream value is supplied by antibodies, primers and probes, sequencing reagents, reference materials, biospecimens, instrument platforms, and bioinformatics tools. Midstream providers combine biomarker science, assay development, clinical laboratory operations, biostatistics, quality management, and regulatory strategy into an evidence package suitable for review. Downstream customers are primarily pharmaceutical and biotechnology companies, with diagnostic companies, central laboratories, and regional laboratory networks supporting commercial deployment. Profitability is strongest where providers control proprietary platforms, sample access, regulatory expertise, and global networks, while routine testing and stand-alone method transfer generally carry weaker pricing power.Segment Insights
End-to-end co-development typically carries the highest contract value and customer retention because responsibility continues from biomarker confirmation through approval and commercialization. By platform, next-generation sequencing remains a major growth area for multigene and tumor-agnostic programs, immunohistochemistry retains strong demand in antibody-drug conjugates and protein-expression biomarkers, and digital pathology adds value by improving scoring consistency and enabling continuous-variable cutoff development.Downstream Market Opportunities
Large pharmaceutical companies generally favor partners with global quality systems and commercialization capabilities, while emerging biotechnology companies place greater emphasis on early strategy, flexible development, and capital efficiency. Diagnostic companies and contract research organizations outsource to fill gaps in specialized platforms, clinical specimens, regulatory expertise, or regional laboratory coverage, whereas academic institutions mainly contribute to early biomarker translation and technical validation.Regional Insights
North America maintains the largest demand base because of its concentration of innovative drug pipelines, established diagnostic companies, and comparatively mature coordinated review mechanisms. Europe has strong molecular and pathology capabilities, although IVDR clinical-evidence requirements and coordination among notified bodies and medicines authorities increase program complexity. Asia-Pacific is expanding rapidly as precision-therapy development, regional trials, and local registration activity grow in China, Japan, and South Korea, creating opportunities in local sample testing and cross-border technology transfer.Competitive Landscape Analysis
The market includes three principal competitor groups. Global central laboratories and CROs provide integrated development through multiregional trial operations; major diagnostic platform companies use installed instruments, standardized reagents, and regulatory experience to support distributed commercialization; and specialist biomarker laboratories and digital pathology companies differentiate through particular technologies, specimen types, or algorithm development. Sustainable advantage depends on controlling scientific feasibility, timelines, quality systems, regulatory interaction, and post-approval deployment rather than test throughput alone.Report Scope
This report is a detailed and comprehensive analysis for global Companion Diagnostic Development Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.Key Features:
Global Companion Diagnostic Development Services market size and forecasts, in consumption value ($ Million), 2021-2032Global Companion Diagnostic Development Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Companion Diagnostic Development Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Companion Diagnostic Development Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Companion Diagnostic Development Services
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Companion Diagnostic Development Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
- Next-Generation Sequencing
- PCR and Digital PCR
- Immunohistochemistry and ISH
- Flow Cytometry
- Immunoassays
- Others
Market segment by Development Stage
- Discovery and Preclinical
- Early Clinical Development
- Pivotal Clinical Development
- Regulatory Submission
- Commercial Launch
- Post-Approval Lifecycle
Market segment by Application
- Pharmaceutical Companies
- Biotechnology Companies
- IVD and Diagnostic Companies
- Academic and Research Institutions
- Others
Market segment by players, this report covers
- Labcorp
- IQVIA Laboratories
- NeoGenomics
- Almac Diagnostic Services
- Precision for Medicine
- Cerba Research
- Eurofins Clinical Diagnostics
- Medpace
- CellCarta
- Foundation Medicine
- Guardant Health
- PathAI
- Geneseeq
- Sysmex Inostics
- Thermo Fisher Scientific
- Agilent Technologies
- Leica Biosystems
- Roche Diagnostics
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Companion Diagnostic Development Services product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Companion Diagnostic Development Services, with revenue, gross margin, and global market share of Companion Diagnostic Development Services from 2021 to 2026.
Chapter 3, the Companion Diagnostic Development Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Companion Diagnostic Development Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Diagnostic Development Services.
Chapter 13, to describe Companion Diagnostic Development Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Companion Diagnostic Development Services by Type
1.3.1 Overview: Global Companion Diagnostic Development Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Companion Diagnostic Development Services Consumption Value Market Share by Type in 2025
1.3.3 Next-Generation Sequencing
1.3.4 PCR and Digital PCR
1.3.5 Immunohistochemistry and ISH
1.3.6 Flow Cytometry
1.3.7 Immunoassays
1.3.8 Others
1.4 Classification of Companion Diagnostic Development Services by Development Stage
1.4.1 Overview: Global Companion Diagnostic Development Services Market Size by Development Stage: 2021 Versus 2025 Versus 2032
1.4.2 Global Companion Diagnostic Development Services Consumption Value Market Share by Development Stage in 2025
1.4.3 Discovery and Preclinical
1.4.4 Early Clinical Development
1.4.5 Pivotal Clinical Development
1.4.6 Regulatory Submission
1.4.7 Commercial Launch
1.4.8 Post-Approval Lifecycle
1.5 Global Companion Diagnostic Development Services Market by Application
1.5.1 Overview: Global Companion Diagnostic Development Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.5.2 Pharmaceutical Companies
1.5.3 Biotechnology Companies
1.5.4 IVD and Diagnostic Companies
1.5.5 Academic and Research Institutions
1.5.6 Others
1.6 Global Companion Diagnostic Development Services Market Size & Forecast
1.7 Global Companion Diagnostic Development Services Market Size and Forecast by Region
1.7.1 Global Companion Diagnostic Development Services Market Size by Region: 2021 VS 2025 VS 2032
1.7.2 Global Companion Diagnostic Development Services Market Size by Region, (2021-2032)
1.7.3 North America Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
1.7.4 Europe Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
1.7.5 Asia-Pacific Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
1.7.6 South America Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
1.7.7 Middle East & Africa Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Labcorp
2.1.1 Labcorp Details
2.1.2 Labcorp Major Business
2.1.3 Labcorp Companion Diagnostic Development Services Product and Solutions
2.1.4 Labcorp Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Labcorp Recent Developments and Future Plans
2.2 IQVIA Laboratories
2.2.1 IQVIA Laboratories Details
2.2.2 IQVIA Laboratories Major Business
2.2.3 IQVIA Laboratories Companion Diagnostic Development Services Product and Solutions
2.2.4 IQVIA Laboratories Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 IQVIA Laboratories Recent Developments and Future Plans
2.3 NeoGenomics
2.3.1 NeoGenomics Details
2.3.2 NeoGenomics Major Business
2.3.3 NeoGenomics Companion Diagnostic Development Services Product and Solutions
2.3.4 NeoGenomics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 NeoGenomics Recent Developments and Future Plans
2.4 Almac Diagnostic Services
2.4.1 Almac Diagnostic Services Details
2.4.2 Almac Diagnostic Services Major Business
2.4.3 Almac Diagnostic Services Companion Diagnostic Development Services Product and Solutions
2.4.4 Almac Diagnostic Services Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Almac Diagnostic Services Recent Developments and Future Plans
2.5 Precision for Medicine
2.5.1 Precision for Medicine Details
2.5.2 Precision for Medicine Major Business
2.5.3 Precision for Medicine Companion Diagnostic Development Services Product and Solutions
2.5.4 Precision for Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Precision for Medicine Recent Developments and Future Plans
2.6 Cerba Research
2.6.1 Cerba Research Details
2.6.2 Cerba Research Major Business
2.6.3 Cerba Research Companion Diagnostic Development Services Product and Solutions
2.6.4 Cerba Research Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Cerba Research Recent Developments and Future Plans
2.7 Eurofins Clinical Diagnostics
2.7.1 Eurofins Clinical Diagnostics Details
2.7.2 Eurofins Clinical Diagnostics Major Business
2.7.3 Eurofins Clinical Diagnostics Companion Diagnostic Development Services Product and Solutions
2.7.4 Eurofins Clinical Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Eurofins Clinical Diagnostics Recent Developments and Future Plans
2.8 Medpace
2.8.1 Medpace Details
2.8.2 Medpace Major Business
2.8.3 Medpace Companion Diagnostic Development Services Product and Solutions
2.8.4 Medpace Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Medpace Recent Developments and Future Plans
2.9 CellCarta
2.9.1 CellCarta Details
2.9.2 CellCarta Major Business
2.9.3 CellCarta Companion Diagnostic Development Services Product and Solutions
2.9.4 CellCarta Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CellCarta Recent Developments and Future Plans
2.10 Foundation Medicine
2.10.1 Foundation Medicine Details
2.10.2 Foundation Medicine Major Business
2.10.3 Foundation Medicine Companion Diagnostic Development Services Product and Solutions
2.10.4 Foundation Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Foundation Medicine Recent Developments and Future Plans
2.11 Guardant Health
2.11.1 Guardant Health Details
2.11.2 Guardant Health Major Business
2.11.3 Guardant Health Companion Diagnostic Development Services Product and Solutions
2.11.4 Guardant Health Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Guardant Health Recent Developments and Future Plans
2.12 PathAI
2.12.1 PathAI Details
2.12.2 PathAI Major Business
2.12.3 PathAI Companion Diagnostic Development Services Product and Solutions
2.12.4 PathAI Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 PathAI Recent Developments and Future Plans
2.13 Geneseeq
2.13.1 Geneseeq Details
2.13.2 Geneseeq Major Business
2.13.3 Geneseeq Companion Diagnostic Development Services Product and Solutions
2.13.4 Geneseeq Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Geneseeq Recent Developments and Future Plans
2.14 Sysmex Inostics
2.14.1 Sysmex Inostics Details
2.14.2 Sysmex Inostics Major Business
2.14.3 Sysmex Inostics Companion Diagnostic Development Services Product and Solutions
2.14.4 Sysmex Inostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sysmex Inostics Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Companion Diagnostic Development Services Product and Solutions
2.15.4 Thermo Fisher Scientific Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.16 Agilent Technologies
2.16.1 Agilent Technologies Details
2.16.2 Agilent Technologies Major Business
2.16.3 Agilent Technologies Companion Diagnostic Development Services Product and Solutions
2.16.4 Agilent Technologies Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Agilent Technologies Recent Developments and Future Plans
2.17 Leica Biosystems
2.17.1 Leica Biosystems Details
2.17.2 Leica Biosystems Major Business
2.17.3 Leica Biosystems Companion Diagnostic Development Services Product and Solutions
2.17.4 Leica Biosystems Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Leica Biosystems Recent Developments and Future Plans
2.18 Roche Diagnostics
2.18.1 Roche Diagnostics Details
2.18.2 Roche Diagnostics Major Business
2.18.3 Roche Diagnostics Companion Diagnostic Development Services Product and Solutions
2.18.4 Roche Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Roche Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Companion Diagnostic Development Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Companion Diagnostic Development Services by Company Revenue
3.2.2 Top 3 Companion Diagnostic Development Services Players Market Share in 2025
3.2.3 Top 6 Companion Diagnostic Development Services Players Market Share in 2025
3.3 Companion Diagnostic Development Services Market: Overall Company Footprint Analysis
3.3.1 Companion Diagnostic Development Services Market: Region Footprint
3.3.2 Companion Diagnostic Development Services Market: Company Product Type Footprint
3.3.3 Companion Diagnostic Development Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Companion Diagnostic Development Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Companion Diagnostic Development Services Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Companion Diagnostic Development Services Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
6.2 North America Companion Diagnostic Development Services Market Size by Application (2021-2032)
6.3 North America Companion Diagnostic Development Services Market Size by Country
6.3.1 North America Companion Diagnostic Development Services Consumption Value by Country (2021-2032)
6.3.2 United States Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
6.3.3 Canada Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
7.2 Europe Companion Diagnostic Development Services Consumption Value by Application (2021-2032)
7.3 Europe Companion Diagnostic Development Services Market Size by Country
7.3.1 Europe Companion Diagnostic Development Services Consumption Value by Country (2021-2032)
7.3.2 Germany Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7.3.3 France Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7.3.5 Russia Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7.3.6 Italy Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Companion Diagnostic Development Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Companion Diagnostic Development Services Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostic Development Services Consumption Value by Region (2021-2032)
8.3.2 China Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.3 Japan Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.5 India Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.7 Australia Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
9.2 South America Companion Diagnostic Development Services Consumption Value by Application (2021-2032)
9.3 South America Companion Diagnostic Development Services Market Size by Country
9.3.1 South America Companion Diagnostic Development Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Companion Diagnostic Development Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Companion Diagnostic Development Services Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostic Development Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
10.3.4 UAE Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Companion Diagnostic Development Services Market Drivers
11.2 Companion Diagnostic Development Services Market Restraints
11.3 Companion Diagnostic Development Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Companion Diagnostic Development Services Industry Chain
12.2 Companion Diagnostic Development Services Upstream Analysis
12.3 Companion Diagnostic Development Services Midstream Analysis
12.4 Companion Diagnostic Development Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Companion Diagnostic Development Services by Type
1.3.1 Overview: Global Companion Diagnostic Development Services Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Companion Diagnostic Development Services Consumption Value Market Share by Type in 2025
1.3.3 Next-Generation Sequencing
1.3.4 PCR and Digital PCR
1.3.5 Immunohistochemistry and ISH
1.3.6 Flow Cytometry
1.3.7 Immunoassays
1.3.8 Others
1.4 Classification of Companion Diagnostic Development Services by Development Stage
1.4.1 Overview: Global Companion Diagnostic Development Services Market Size by Development Stage: 2021 Versus 2025 Versus 2032
1.4.2 Global Companion Diagnostic Development Services Consumption Value Market Share by Development Stage in 2025
1.4.3 Discovery and Preclinical
1.4.4 Early Clinical Development
1.4.5 Pivotal Clinical Development
1.4.6 Regulatory Submission
1.4.7 Commercial Launch
1.4.8 Post-Approval Lifecycle
1.5 Global Companion Diagnostic Development Services Market by Application
1.5.1 Overview: Global Companion Diagnostic Development Services Market Size by Application: 2021 Versus 2025 Versus 2032
1.5.2 Pharmaceutical Companies
1.5.3 Biotechnology Companies
1.5.4 IVD and Diagnostic Companies
1.5.5 Academic and Research Institutions
1.5.6 Others
1.6 Global Companion Diagnostic Development Services Market Size & Forecast
1.7 Global Companion Diagnostic Development Services Market Size and Forecast by Region
1.7.1 Global Companion Diagnostic Development Services Market Size by Region: 2021 VS 2025 VS 2032
1.7.2 Global Companion Diagnostic Development Services Market Size by Region, (2021-2032)
1.7.3 North America Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
1.7.4 Europe Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
1.7.5 Asia-Pacific Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
1.7.6 South America Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
1.7.7 Middle East & Africa Companion Diagnostic Development Services Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Labcorp
2.1.1 Labcorp Details
2.1.2 Labcorp Major Business
2.1.3 Labcorp Companion Diagnostic Development Services Product and Solutions
2.1.4 Labcorp Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Labcorp Recent Developments and Future Plans
2.2 IQVIA Laboratories
2.2.1 IQVIA Laboratories Details
2.2.2 IQVIA Laboratories Major Business
2.2.3 IQVIA Laboratories Companion Diagnostic Development Services Product and Solutions
2.2.4 IQVIA Laboratories Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 IQVIA Laboratories Recent Developments and Future Plans
2.3 NeoGenomics
2.3.1 NeoGenomics Details
2.3.2 NeoGenomics Major Business
2.3.3 NeoGenomics Companion Diagnostic Development Services Product and Solutions
2.3.4 NeoGenomics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 NeoGenomics Recent Developments and Future Plans
2.4 Almac Diagnostic Services
2.4.1 Almac Diagnostic Services Details
2.4.2 Almac Diagnostic Services Major Business
2.4.3 Almac Diagnostic Services Companion Diagnostic Development Services Product and Solutions
2.4.4 Almac Diagnostic Services Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Almac Diagnostic Services Recent Developments and Future Plans
2.5 Precision for Medicine
2.5.1 Precision for Medicine Details
2.5.2 Precision for Medicine Major Business
2.5.3 Precision for Medicine Companion Diagnostic Development Services Product and Solutions
2.5.4 Precision for Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Precision for Medicine Recent Developments and Future Plans
2.6 Cerba Research
2.6.1 Cerba Research Details
2.6.2 Cerba Research Major Business
2.6.3 Cerba Research Companion Diagnostic Development Services Product and Solutions
2.6.4 Cerba Research Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Cerba Research Recent Developments and Future Plans
2.7 Eurofins Clinical Diagnostics
2.7.1 Eurofins Clinical Diagnostics Details
2.7.2 Eurofins Clinical Diagnostics Major Business
2.7.3 Eurofins Clinical Diagnostics Companion Diagnostic Development Services Product and Solutions
2.7.4 Eurofins Clinical Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Eurofins Clinical Diagnostics Recent Developments and Future Plans
2.8 Medpace
2.8.1 Medpace Details
2.8.2 Medpace Major Business
2.8.3 Medpace Companion Diagnostic Development Services Product and Solutions
2.8.4 Medpace Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Medpace Recent Developments and Future Plans
2.9 CellCarta
2.9.1 CellCarta Details
2.9.2 CellCarta Major Business
2.9.3 CellCarta Companion Diagnostic Development Services Product and Solutions
2.9.4 CellCarta Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CellCarta Recent Developments and Future Plans
2.10 Foundation Medicine
2.10.1 Foundation Medicine Details
2.10.2 Foundation Medicine Major Business
2.10.3 Foundation Medicine Companion Diagnostic Development Services Product and Solutions
2.10.4 Foundation Medicine Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Foundation Medicine Recent Developments and Future Plans
2.11 Guardant Health
2.11.1 Guardant Health Details
2.11.2 Guardant Health Major Business
2.11.3 Guardant Health Companion Diagnostic Development Services Product and Solutions
2.11.4 Guardant Health Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Guardant Health Recent Developments and Future Plans
2.12 PathAI
2.12.1 PathAI Details
2.12.2 PathAI Major Business
2.12.3 PathAI Companion Diagnostic Development Services Product and Solutions
2.12.4 PathAI Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 PathAI Recent Developments and Future Plans
2.13 Geneseeq
2.13.1 Geneseeq Details
2.13.2 Geneseeq Major Business
2.13.3 Geneseeq Companion Diagnostic Development Services Product and Solutions
2.13.4 Geneseeq Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Geneseeq Recent Developments and Future Plans
2.14 Sysmex Inostics
2.14.1 Sysmex Inostics Details
2.14.2 Sysmex Inostics Major Business
2.14.3 Sysmex Inostics Companion Diagnostic Development Services Product and Solutions
2.14.4 Sysmex Inostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sysmex Inostics Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Companion Diagnostic Development Services Product and Solutions
2.15.4 Thermo Fisher Scientific Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.16 Agilent Technologies
2.16.1 Agilent Technologies Details
2.16.2 Agilent Technologies Major Business
2.16.3 Agilent Technologies Companion Diagnostic Development Services Product and Solutions
2.16.4 Agilent Technologies Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Agilent Technologies Recent Developments and Future Plans
2.17 Leica Biosystems
2.17.1 Leica Biosystems Details
2.17.2 Leica Biosystems Major Business
2.17.3 Leica Biosystems Companion Diagnostic Development Services Product and Solutions
2.17.4 Leica Biosystems Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Leica Biosystems Recent Developments and Future Plans
2.18 Roche Diagnostics
2.18.1 Roche Diagnostics Details
2.18.2 Roche Diagnostics Major Business
2.18.3 Roche Diagnostics Companion Diagnostic Development Services Product and Solutions
2.18.4 Roche Diagnostics Companion Diagnostic Development Services Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Roche Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Companion Diagnostic Development Services Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Companion Diagnostic Development Services by Company Revenue
3.2.2 Top 3 Companion Diagnostic Development Services Players Market Share in 2025
3.2.3 Top 6 Companion Diagnostic Development Services Players Market Share in 2025
3.3 Companion Diagnostic Development Services Market: Overall Company Footprint Analysis
3.3.1 Companion Diagnostic Development Services Market: Region Footprint
3.3.2 Companion Diagnostic Development Services Market: Company Product Type Footprint
3.3.3 Companion Diagnostic Development Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Companion Diagnostic Development Services Consumption Value and Market Share by Type (2021-2026)
4.2 Global Companion Diagnostic Development Services Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2026)
5.2 Global Companion Diagnostic Development Services Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
6.2 North America Companion Diagnostic Development Services Market Size by Application (2021-2032)
6.3 North America Companion Diagnostic Development Services Market Size by Country
6.3.1 North America Companion Diagnostic Development Services Consumption Value by Country (2021-2032)
6.3.2 United States Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
6.3.3 Canada Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
6.3.4 Mexico Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
7.2 Europe Companion Diagnostic Development Services Consumption Value by Application (2021-2032)
7.3 Europe Companion Diagnostic Development Services Market Size by Country
7.3.1 Europe Companion Diagnostic Development Services Consumption Value by Country (2021-2032)
7.3.2 Germany Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7.3.3 France Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7.3.5 Russia Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
7.3.6 Italy Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Companion Diagnostic Development Services Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Companion Diagnostic Development Services Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostic Development Services Consumption Value by Region (2021-2032)
8.3.2 China Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.3 Japan Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.4 South Korea Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.5 India Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
8.3.7 Australia Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
9.2 South America Companion Diagnostic Development Services Consumption Value by Application (2021-2032)
9.3 South America Companion Diagnostic Development Services Market Size by Country
9.3.1 South America Companion Diagnostic Development Services Consumption Value by Country (2021-2032)
9.3.2 Brazil Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
9.3.3 Argentina Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Companion Diagnostic Development Services Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Companion Diagnostic Development Services Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Companion Diagnostic Development Services Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostic Development Services Consumption Value by Country (2021-2032)
10.3.2 Turkey Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
10.3.4 UAE Companion Diagnostic Development Services Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Companion Diagnostic Development Services Market Drivers
11.2 Companion Diagnostic Development Services Market Restraints
11.3 Companion Diagnostic Development Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Companion Diagnostic Development Services Industry Chain
12.2 Companion Diagnostic Development Services Upstream Analysis
12.3 Companion Diagnostic Development Services Midstream Analysis
12.4 Companion Diagnostic Development Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Companion Diagnostic Development Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Companion Diagnostic Development Services Consumption Value by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 3. Global Companion Diagnostic Development Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Companion Diagnostic Development Services Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Companion Diagnostic Development Services Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Labcorp Company Information, Head Office, and Major Competitors
Table 7. Labcorp Major Business
Table 8. Labcorp Companion Diagnostic Development Services Product and Solutions
Table 9. Labcorp Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Labcorp Recent Developments and Future Plans
Table 11. IQVIA Laboratories Company Information, Head Office, and Major Competitors
Table 12. IQVIA Laboratories Major Business
Table 13. IQVIA Laboratories Companion Diagnostic Development Services Product and Solutions
Table 14. IQVIA Laboratories Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. IQVIA Laboratories Recent Developments and Future Plans
Table 16. NeoGenomics Company Information, Head Office, and Major Competitors
Table 17. NeoGenomics Major Business
Table 18. NeoGenomics Companion Diagnostic Development Services Product and Solutions
Table 19. NeoGenomics Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Almac Diagnostic Services Company Information, Head Office, and Major Competitors
Table 21. Almac Diagnostic Services Major Business
Table 22. Almac Diagnostic Services Companion Diagnostic Development Services Product and Solutions
Table 23. Almac Diagnostic Services Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Almac Diagnostic Services Recent Developments and Future Plans
Table 25. Precision for Medicine Company Information, Head Office, and Major Competitors
Table 26. Precision for Medicine Major Business
Table 27. Precision for Medicine Companion Diagnostic Development Services Product and Solutions
Table 28. Precision for Medicine Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Precision for Medicine Recent Developments and Future Plans
Table 30. Cerba Research Company Information, Head Office, and Major Competitors
Table 31. Cerba Research Major Business
Table 32. Cerba Research Companion Diagnostic Development Services Product and Solutions
Table 33. Cerba Research Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Cerba Research Recent Developments and Future Plans
Table 35. Eurofins Clinical Diagnostics Company Information, Head Office, and Major Competitors
Table 36. Eurofins Clinical Diagnostics Major Business
Table 37. Eurofins Clinical Diagnostics Companion Diagnostic Development Services Product and Solutions
Table 38. Eurofins Clinical Diagnostics Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Eurofins Clinical Diagnostics Recent Developments and Future Plans
Table 40. Medpace Company Information, Head Office, and Major Competitors
Table 41. Medpace Major Business
Table 42. Medpace Companion Diagnostic Development Services Product and Solutions
Table 43. Medpace Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Medpace Recent Developments and Future Plans
Table 45. CellCarta Company Information, Head Office, and Major Competitors
Table 46. CellCarta Major Business
Table 47. CellCarta Companion Diagnostic Development Services Product and Solutions
Table 48. CellCarta Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. CellCarta Recent Developments and Future Plans
Table 50. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 51. Foundation Medicine Major Business
Table 52. Foundation Medicine Companion Diagnostic Development Services Product and Solutions
Table 53. Foundation Medicine Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Foundation Medicine Recent Developments and Future Plans
Table 55. Guardant Health Company Information, Head Office, and Major Competitors
Table 56. Guardant Health Major Business
Table 57. Guardant Health Companion Diagnostic Development Services Product and Solutions
Table 58. Guardant Health Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Guardant Health Recent Developments and Future Plans
Table 60. PathAI Company Information, Head Office, and Major Competitors
Table 61. PathAI Major Business
Table 62. PathAI Companion Diagnostic Development Services Product and Solutions
Table 63. PathAI Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. PathAI Recent Developments and Future Plans
Table 65. Geneseeq Company Information, Head Office, and Major Competitors
Table 66. Geneseeq Major Business
Table 67. Geneseeq Companion Diagnostic Development Services Product and Solutions
Table 68. Geneseeq Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Geneseeq Recent Developments and Future Plans
Table 70. Sysmex Inostics Company Information, Head Office, and Major Competitors
Table 71. Sysmex Inostics Major Business
Table 72. Sysmex Inostics Companion Diagnostic Development Services Product and Solutions
Table 73. Sysmex Inostics Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Sysmex Inostics Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific Companion Diagnostic Development Services Product and Solutions
Table 78. Thermo Fisher Scientific Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Thermo Fisher Scientific Recent Developments and Future Plans
Table 80. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 81. Agilent Technologies Major Business
Table 82. Agilent Technologies Companion Diagnostic Development Services Product and Solutions
Table 83. Agilent Technologies Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Agilent Technologies Recent Developments and Future Plans
Table 85. Leica Biosystems Company Information, Head Office, and Major Competitors
Table 86. Leica Biosystems Major Business
Table 87. Leica Biosystems Companion Diagnostic Development Services Product and Solutions
Table 88. Leica Biosystems Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Leica Biosystems Recent Developments and Future Plans
Table 90. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 91. Roche Diagnostics Major Business
Table 92. Roche Diagnostics Companion Diagnostic Development Services Product and Solutions
Table 93. Roche Diagnostics Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Roche Diagnostics Recent Developments and Future Plans
Table 95. Global Companion Diagnostic Development Services Revenue (USD Million) by Players (2021-2026)
Table 96. Global Companion Diagnostic Development Services Revenue Share by Players (2021-2026)
Table 97. Breakdown of Companion Diagnostic Development Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Companion Diagnostic Development Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 99. Head Office of Key Companion Diagnostic Development Services Players
Table 100. Companion Diagnostic Development Services Market: Company Product Type Footprint
Table 101. Companion Diagnostic Development Services Market: Company Product Application Footprint
Table 102. Companion Diagnostic Development Services New Market Entrants and Barriers to Market Entry
Table 103. Companion Diagnostic Development Services Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Companion Diagnostic Development Services Consumption Value (USD Million) by Type (2021-2026)
Table 105. Global Companion Diagnostic Development Services Consumption Value Share by Type (2021-2026)
Table 106. Global Companion Diagnostic Development Services Consumption Value Forecast by Type (2027-2032)
Table 107. Global Companion Diagnostic Development Services Consumption Value by Application (2021-2026)
Table 108. Global Companion Diagnostic Development Services Consumption Value Forecast by Application (2027-2032)
Table 109. North America Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 110. North America Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 111. North America Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 112. North America Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 113. North America Companion Diagnostic Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 114. North America Companion Diagnostic Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 115. Europe Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 116. Europe Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 117. Europe Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Europe Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Europe Companion Diagnostic Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Europe Companion Diagnostic Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 124. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 125. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Region (2021-2026) & (USD Million)
Table 126. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Region (2027-2032) & (USD Million)
Table 127. South America Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 128. South America Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 129. South America Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 130. South America Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 131. South America Companion Diagnostic Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 132. South America Companion Diagnostic Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 134. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 135. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 136. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 137. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 138. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Global Key Players of Companion Diagnostic Development Services Upstream (Raw Materials)
Table 140. Global Companion Diagnostic Development Services Typical Customers
Table 1. Global Companion Diagnostic Development Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Companion Diagnostic Development Services Consumption Value by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 3. Global Companion Diagnostic Development Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Companion Diagnostic Development Services Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Companion Diagnostic Development Services Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Labcorp Company Information, Head Office, and Major Competitors
Table 7. Labcorp Major Business
Table 8. Labcorp Companion Diagnostic Development Services Product and Solutions
Table 9. Labcorp Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Labcorp Recent Developments and Future Plans
Table 11. IQVIA Laboratories Company Information, Head Office, and Major Competitors
Table 12. IQVIA Laboratories Major Business
Table 13. IQVIA Laboratories Companion Diagnostic Development Services Product and Solutions
Table 14. IQVIA Laboratories Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. IQVIA Laboratories Recent Developments and Future Plans
Table 16. NeoGenomics Company Information, Head Office, and Major Competitors
Table 17. NeoGenomics Major Business
Table 18. NeoGenomics Companion Diagnostic Development Services Product and Solutions
Table 19. NeoGenomics Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Almac Diagnostic Services Company Information, Head Office, and Major Competitors
Table 21. Almac Diagnostic Services Major Business
Table 22. Almac Diagnostic Services Companion Diagnostic Development Services Product and Solutions
Table 23. Almac Diagnostic Services Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Almac Diagnostic Services Recent Developments and Future Plans
Table 25. Precision for Medicine Company Information, Head Office, and Major Competitors
Table 26. Precision for Medicine Major Business
Table 27. Precision for Medicine Companion Diagnostic Development Services Product and Solutions
Table 28. Precision for Medicine Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Precision for Medicine Recent Developments and Future Plans
Table 30. Cerba Research Company Information, Head Office, and Major Competitors
Table 31. Cerba Research Major Business
Table 32. Cerba Research Companion Diagnostic Development Services Product and Solutions
Table 33. Cerba Research Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Cerba Research Recent Developments and Future Plans
Table 35. Eurofins Clinical Diagnostics Company Information, Head Office, and Major Competitors
Table 36. Eurofins Clinical Diagnostics Major Business
Table 37. Eurofins Clinical Diagnostics Companion Diagnostic Development Services Product and Solutions
Table 38. Eurofins Clinical Diagnostics Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Eurofins Clinical Diagnostics Recent Developments and Future Plans
Table 40. Medpace Company Information, Head Office, and Major Competitors
Table 41. Medpace Major Business
Table 42. Medpace Companion Diagnostic Development Services Product and Solutions
Table 43. Medpace Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Medpace Recent Developments and Future Plans
Table 45. CellCarta Company Information, Head Office, and Major Competitors
Table 46. CellCarta Major Business
Table 47. CellCarta Companion Diagnostic Development Services Product and Solutions
Table 48. CellCarta Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. CellCarta Recent Developments and Future Plans
Table 50. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 51. Foundation Medicine Major Business
Table 52. Foundation Medicine Companion Diagnostic Development Services Product and Solutions
Table 53. Foundation Medicine Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Foundation Medicine Recent Developments and Future Plans
Table 55. Guardant Health Company Information, Head Office, and Major Competitors
Table 56. Guardant Health Major Business
Table 57. Guardant Health Companion Diagnostic Development Services Product and Solutions
Table 58. Guardant Health Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Guardant Health Recent Developments and Future Plans
Table 60. PathAI Company Information, Head Office, and Major Competitors
Table 61. PathAI Major Business
Table 62. PathAI Companion Diagnostic Development Services Product and Solutions
Table 63. PathAI Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. PathAI Recent Developments and Future Plans
Table 65. Geneseeq Company Information, Head Office, and Major Competitors
Table 66. Geneseeq Major Business
Table 67. Geneseeq Companion Diagnostic Development Services Product and Solutions
Table 68. Geneseeq Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Geneseeq Recent Developments and Future Plans
Table 70. Sysmex Inostics Company Information, Head Office, and Major Competitors
Table 71. Sysmex Inostics Major Business
Table 72. Sysmex Inostics Companion Diagnostic Development Services Product and Solutions
Table 73. Sysmex Inostics Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Sysmex Inostics Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Major Business
Table 77. Thermo Fisher Scientific Companion Diagnostic Development Services Product and Solutions
Table 78. Thermo Fisher Scientific Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Thermo Fisher Scientific Recent Developments and Future Plans
Table 80. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 81. Agilent Technologies Major Business
Table 82. Agilent Technologies Companion Diagnostic Development Services Product and Solutions
Table 83. Agilent Technologies Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Agilent Technologies Recent Developments and Future Plans
Table 85. Leica Biosystems Company Information, Head Office, and Major Competitors
Table 86. Leica Biosystems Major Business
Table 87. Leica Biosystems Companion Diagnostic Development Services Product and Solutions
Table 88. Leica Biosystems Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Leica Biosystems Recent Developments and Future Plans
Table 90. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 91. Roche Diagnostics Major Business
Table 92. Roche Diagnostics Companion Diagnostic Development Services Product and Solutions
Table 93. Roche Diagnostics Companion Diagnostic Development Services Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Roche Diagnostics Recent Developments and Future Plans
Table 95. Global Companion Diagnostic Development Services Revenue (USD Million) by Players (2021-2026)
Table 96. Global Companion Diagnostic Development Services Revenue Share by Players (2021-2026)
Table 97. Breakdown of Companion Diagnostic Development Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Companion Diagnostic Development Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 99. Head Office of Key Companion Diagnostic Development Services Players
Table 100. Companion Diagnostic Development Services Market: Company Product Type Footprint
Table 101. Companion Diagnostic Development Services Market: Company Product Application Footprint
Table 102. Companion Diagnostic Development Services New Market Entrants and Barriers to Market Entry
Table 103. Companion Diagnostic Development Services Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Companion Diagnostic Development Services Consumption Value (USD Million) by Type (2021-2026)
Table 105. Global Companion Diagnostic Development Services Consumption Value Share by Type (2021-2026)
Table 106. Global Companion Diagnostic Development Services Consumption Value Forecast by Type (2027-2032)
Table 107. Global Companion Diagnostic Development Services Consumption Value by Application (2021-2026)
Table 108. Global Companion Diagnostic Development Services Consumption Value Forecast by Application (2027-2032)
Table 109. North America Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 110. North America Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 111. North America Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 112. North America Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 113. North America Companion Diagnostic Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 114. North America Companion Diagnostic Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 115. Europe Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 116. Europe Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 117. Europe Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Europe Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Europe Companion Diagnostic Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Europe Companion Diagnostic Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 124. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 125. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Region (2021-2026) & (USD Million)
Table 126. Asia-Pacific Companion Diagnostic Development Services Consumption Value by Region (2027-2032) & (USD Million)
Table 127. South America Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 128. South America Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 129. South America Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 130. South America Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 131. South America Companion Diagnostic Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 132. South America Companion Diagnostic Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Type (2021-2026) & (USD Million)
Table 134. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Type (2027-2032) & (USD Million)
Table 135. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Application (2021-2026) & (USD Million)
Table 136. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Application (2027-2032) & (USD Million)
Table 137. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Country (2021-2026) & (USD Million)
Table 138. Middle East & Africa Companion Diagnostic Development Services Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Global Key Players of Companion Diagnostic Development Services Upstream (Raw Materials)
Table 140. Global Companion Diagnostic Development Services Typical Customers
LIST OF FIGURES
Figure 1. Companion Diagnostic Development Services Picture
Figure 2. Global Companion Diagnostic Development Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Companion Diagnostic Development Services Consumption Value Market Share by Type in 2025
Figure 4. Next-Generation Sequencing
Figure 5. PCR and Digital PCR
Figure 6. Immunohistochemistry and ISH
Figure 7. Flow Cytometry
Figure 8. Immunoassays
Figure 9. Others
Figure 10. Global Companion Diagnostic Development Services Consumption Value by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Companion Diagnostic Development Services Consumption Value Market Share by Development Stage in 2025
Figure 12. Discovery and Preclinical
Figure 13. Early Clinical Development
Figure 14. Pivotal Clinical Development
Figure 15. Regulatory Submission
Figure 16. Commercial Launch
Figure 17. Post-Approval Lifecycle
Figure 18. Global Companion Diagnostic Development Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Companion Diagnostic Development Services Consumption Value Market Share by Application in 2025
Figure 20. Pharmaceutical Companies Picture
Figure 21. Biotechnology Companies Picture
Figure 22. IVD and Diagnostic Companies Picture
Figure 23. Academic and Research Institutions Picture
Figure 24. Others Picture
Figure 25. Global Companion Diagnostic Development Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Companion Diagnostic Development Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Market Companion Diagnostic Development Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 28. Global Companion Diagnostic Development Services Consumption Value Market Share by Region (2021-2032)
Figure 29. Global Companion Diagnostic Development Services Consumption Value Market Share by Region in 2025
Figure 30. North America Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 35. Company Three Recent Developments and Future Plans
Figure 36. Global Companion Diagnostic Development Services Revenue Share by Players in 2025
Figure 37. Companion Diagnostic Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 38. Market Share of Companion Diagnostic Development Services by Player Revenue in 2025
Figure 39. Top 3 Companion Diagnostic Development Services Players Market Share in 2025
Figure 40. Top 6 Companion Diagnostic Development Services Players Market Share in 2025
Figure 41. Global Companion Diagnostic Development Services Consumption Value Share by Type (2021-2026)
Figure 42. Global Companion Diagnostic Development Services Market Share Forecast by Type (2027-2032)
Figure 43. Global Companion Diagnostic Development Services Consumption Value Share by Application (2021-2026)
Figure 44. Global Companion Diagnostic Development Services Market Share Forecast by Application (2027-2032)
Figure 45. North America Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 46. North America Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 47. North America Companion Diagnostic Development Services Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 52. Europe Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 53. Europe Companion Diagnostic Development Services Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 55. France Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Companion Diagnostic Development Services Consumption Value Market Share by Region (2021-2032)
Figure 62. China Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 65. India Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 69. South America Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 70. South America Companion Diagnostic Development Services Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Companion Diagnostic Development Services Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 78. UAE Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 79. Companion Diagnostic Development Services Market Drivers
Figure 80. Companion Diagnostic Development Services Market Restraints
Figure 81. Companion Diagnostic Development Services Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Companion Diagnostic Development Services Industrial Chain
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Companion Diagnostic Development Services Picture
Figure 2. Global Companion Diagnostic Development Services Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Companion Diagnostic Development Services Consumption Value Market Share by Type in 2025
Figure 4. Next-Generation Sequencing
Figure 5. PCR and Digital PCR
Figure 6. Immunohistochemistry and ISH
Figure 7. Flow Cytometry
Figure 8. Immunoassays
Figure 9. Others
Figure 10. Global Companion Diagnostic Development Services Consumption Value by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Companion Diagnostic Development Services Consumption Value Market Share by Development Stage in 2025
Figure 12. Discovery and Preclinical
Figure 13. Early Clinical Development
Figure 14. Pivotal Clinical Development
Figure 15. Regulatory Submission
Figure 16. Commercial Launch
Figure 17. Post-Approval Lifecycle
Figure 18. Global Companion Diagnostic Development Services Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Companion Diagnostic Development Services Consumption Value Market Share by Application in 2025
Figure 20. Pharmaceutical Companies Picture
Figure 21. Biotechnology Companies Picture
Figure 22. IVD and Diagnostic Companies Picture
Figure 23. Academic and Research Institutions Picture
Figure 24. Others Picture
Figure 25. Global Companion Diagnostic Development Services Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Companion Diagnostic Development Services Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Market Companion Diagnostic Development Services Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 28. Global Companion Diagnostic Development Services Consumption Value Market Share by Region (2021-2032)
Figure 29. Global Companion Diagnostic Development Services Consumption Value Market Share by Region in 2025
Figure 30. North America Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 33. South America Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 35. Company Three Recent Developments and Future Plans
Figure 36. Global Companion Diagnostic Development Services Revenue Share by Players in 2025
Figure 37. Companion Diagnostic Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 38. Market Share of Companion Diagnostic Development Services by Player Revenue in 2025
Figure 39. Top 3 Companion Diagnostic Development Services Players Market Share in 2025
Figure 40. Top 6 Companion Diagnostic Development Services Players Market Share in 2025
Figure 41. Global Companion Diagnostic Development Services Consumption Value Share by Type (2021-2026)
Figure 42. Global Companion Diagnostic Development Services Market Share Forecast by Type (2027-2032)
Figure 43. Global Companion Diagnostic Development Services Consumption Value Share by Application (2021-2026)
Figure 44. Global Companion Diagnostic Development Services Market Share Forecast by Application (2027-2032)
Figure 45. North America Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 46. North America Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 47. North America Companion Diagnostic Development Services Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 52. Europe Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 53. Europe Companion Diagnostic Development Services Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 55. France Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 60. Asia-Pacific Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 61. Asia-Pacific Companion Diagnostic Development Services Consumption Value Market Share by Region (2021-2032)
Figure 62. China Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 65. India Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 69. South America Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 70. South America Companion Diagnostic Development Services Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa Companion Diagnostic Development Services Consumption Value Market Share by Type (2021-2032)
Figure 74. Middle East & Africa Companion Diagnostic Development Services Consumption Value Market Share by Application (2021-2032)
Figure 75. Middle East & Africa Companion Diagnostic Development Services Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 77. Saudi Arabia Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 78. UAE Companion Diagnostic Development Services Consumption Value (2021-2032) & (USD Million)
Figure 79. Companion Diagnostic Development Services Market Drivers
Figure 80. Companion Diagnostic Development Services Market Restraints
Figure 81. Companion Diagnostic Development Services Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Companion Diagnostic Development Services Industrial Chain
Figure 84. Methodology
Figure 85. Research Process and Data Source
